Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG.L Regulatory News (MIG)

  • There is currently no data for MIG

Interim Management Statement

12 Sep 2023 10:30

RNS Number : 1745M
Mobeus Income & Growth 2 VCT PLC
12 September 2023
 

MOBEUS INCOME & GROWTH 2 VCT PLC

("the Company")

LEI: 213800LY62XLI1B4VX35

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2023

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 30 June 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 30 June 2023

(unaudited)

At 31 March 2023

(audited)

Net assets attributable to shareholders

£71,597,619

£70,426,557

Shares in issue

98,437,045

98,437,045

Net asset value (NAV) per share

72.73p

71.54p

Cumulative dividends paid

147.00p

147.00p

Cumulative Total return (net asset value basis) per share since inception

219.73p

218.54p

 

Net asset value (NAV) per share has increased by 1.19 pence, or 1.7% over the period. This increase is primarily due to a rise in unrealised valuations over the first three months of the financial year. No dividends have been paid in the period.

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investments

On 3 May 2023, a new equity investment of £0.39 million was made into Dayrize B.V., a provider of a rapid sustainability impact assessment tool.

 

Share Buybacks

No shares were bought back in the quarter.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

New investments after the period end

On 26 July 2023, a new equity investment of £0.32 million was made into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, a new equity investment of £0.32 million was made into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Follow-on investments after the period end

On 4 July 2023, a follow on equity investment of £0.30 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.11 million was made into Orri, an intensive day care provider for adults with eating disorders.

 

Share Buybacks after the period end

On 18 July 2023, the Company purchased 336,876 of its own ordinary shares at a price of 67.96 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary

020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKLLBFXKLLBBX
Date   Source Headline
1st Jul 20157:00 amRNSTotal Voting Rights
29th Jun 20159:45 amRNSTransaction in Own Shares
19th Jun 20155:28 pmRNSAnnual Report
15th Jun 20155:38 pmRNSFinal Results
1st Apr 201512:03 pmRNSTotal Voting Rights
11th Mar 201510:09 amRNSIssue of Equity
27th Feb 20159:26 amRNSOffer Update
23rd Feb 20157:00 amRNSOffer Update
18th Feb 20151:43 pmRNSIssue of Equity
11th Feb 201510:03 amRNSInterim Management Statement
6th Feb 201510:41 amRNSOffer Update
15th Jan 20153:45 pmRNSOffer Update
15th Jan 20151:55 pmRNSDirector/PDMR Shareholding
15th Jan 20151:52 pmRNSIssue of Equity
23rd Dec 201412:32 pmRNSOffer Update
19th Dec 20144:38 pmRNSIssue of Supplementary Prospectus
19th Dec 201411:22 amRNSTransaction in Own Shares
10th Dec 20145:36 pmRNSOffer for Subscription - Launch
21st Nov 20149:32 amRNSHalf Yearly Report
13th Nov 20143:17 pmRNSHalf Yearly Report
22nd Oct 20143:00 pmRNSIntention to launch offers for subscription
22nd Oct 201412:00 pmRNSIntention to launch offers for subscription
1st Oct 201412:28 pmRNSTotal Voting Rights
29th Sep 20145:50 pmRNSTransaction in Own Shares
11th Sep 20143:29 pmRNSAGM Statement
11th Sep 201411:51 amRNSIntermin Dividend
1st Sep 20144:34 pmRNSTotal Voting Rights
1st Aug 20143:25 pmRNSInterim Management Statement
7th Jul 20149:31 amRNSTransaction in Own Shares
24th Jun 201410:45 amRNSTransaction in Own Shares
20th Jun 201412:19 pmRNSAnnual Financial Report
6th Jun 201412:23 pmRNSIssue of Equity
2nd Jun 20149:39 amRNSOffer Update
2nd Jun 20149:37 amRNSOffer Update
2nd Jun 20149:33 amRNSOffer Update
29th Apr 20143:25 pmRNSOffer Update
16th Apr 20145:19 pmRNSOffer Update
7th Apr 20149:55 amRNSIssue of Equity
4th Apr 20149:15 amRNSIssue of Equity
1st Apr 20149:22 amPRNIssue of Equity
31st Mar 201410:05 amPRNTransaction in Own Shares
26th Mar 201410:38 amPRNSupplementary Prospectus
24th Mar 20147:00 amPRNOffer Update
3rd Mar 201410:29 amPRNTransaction in Own Shares
12th Feb 20143:32 pmPRNIssue of Equity
23rd Jan 201412:46 pmPRNTransaction in Own Shares
9th Jan 20145:57 pmPRNIssue of Equity
23rd Dec 20137:00 amPRNHalf-yearly Report - NSM
19th Dec 20132:15 pmPRNIssue of Supplementary Prospectus
19th Dec 20132:14 pmPRNIssue of Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.